Skip to search formSkip to main contentSkip to account menu

alogliptin benzoate

Known as: Benzonitrile, 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)- pyrimidinyl]methyl]-, Monobenzoate 
The benzoate salt form of alogliptin, a selective, orally bioavailable, pyrimidinedione-based inhibitor of dipeptidyl peptidase 4 (DPP-4), with… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Alogliptin benzoate, a member of dipeptidyl peptidase-4 inhibitors, is a recent drug developed by Takeda Pharmaceutical Company… 
2017
2017
A series of structurally well-defined dinickel carboxylate complexes based on the RBiIBTP derivatives [RBiIBTP = bis… 
2015
2015
A new, simple, precise, accurate and selective high performance thin-layer chromatographic (HPTLC) method has been developed and… 
2015
2015
A new, simple, precise, accurate and selective high performance thin-layer chromatographic (HPTLC) method has been developed and… 
2015
2015
A new, simple, precise, accurate and selective high performance thin-layer chromatographic (HPTLC) met hod has been developed and… 
Review
2014
Review
2014
Introduction: Type 2 diabetes mellitus continues to be a global problem, placing an enormous burden on healthcare systems and… 
2014
2014
The characterization of process-related impurities and forced degradants of alogliptin benzoate (Alb) in bulk drugs and a… 
2013
2013
Aim: To evaluate the long-term efficacy of monotherapy with the dipeptidase-4 inhibitor alogliptin benzoate in hemodialysis (HD…